Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07451860

Chronic Total Occlusion and Triglyceride-Glucose Index

The Role of the Triglyceride-Glucose Index in Determining the Risk of Chronic Total Occlusion in Coronary Artery Disease

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
Kırıkkale University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

We retrospectively analyzed 200 CAD patients undergoing coronary angiography between 2026-2027. Patients were grouped by CTO presence. Clinical and laboratory parameters were compared, and logistic regression was performed to identify independent predictors.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTtriglyceride-glucose (TyG) index was calculated from routinely obtained blood samples using the formula: Triglyceride (mg/dL) × Glucose (mg/dL) / 2.As no previous studies have demonstrated the predictive value of the TyG index for chronic total occlusion (CTO), the present investigation provides a novel contribution to the literature. We hypothesize that the triglyceride-glucose (TyG) index will be significantly higher in patients with chronic total occlusion (CTO) compared to those without CTO.

Timeline

Start date
2026-03-15
Primary completion
2026-07-15
Completion
2026-09-15
First posted
2026-03-05
Last updated
2026-03-05

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT07451860. Inclusion in this directory is not an endorsement.